Clinical Trial Update: Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD). [Phase 3]

View source ↗

Summary

Pfizer completed a Phase 3 trial evaluating smoking cessation in adults with mild-to-moderate chronic obstructive pulmonary disease, with results posted in Dece…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• CHANTIX (varenicline tartrate)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED | Results posted: 2009-12-03